Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.